BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2636667)

  • 1. Effect of low dose supplementation of L-carnitine on lipid metabolism in hemodialyzed children.
    Glöggler A; Bulla M; Fürst P
    Kidney Int Suppl; 1989 Nov; 27():S256-8. PubMed ID: 2636667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of L-carnitine supplementation on lipid metabolism of renal failure, dialysis-dependent children and adolescents].
    Böhles H; Michalk D; von Wendt-Göknur E
    Infusionstherapie; 1991 Oct; 18(5):224-6. PubMed ID: 1769735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dialysate composition on the lipid response to L-carnitine supplementation.
    Zilleruelo G; Novak M; Hsia SL; Goldberg R; Abitbol C; Monkus E; Strauss J
    Kidney Int Suppl; 1989 Nov; 27():S259-63. PubMed ID: 2699997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketogenic and antiketogenic effects of L-carnitine in hemodialysis patients.
    Wanner C; Wieland H; Wäckerle B; Boeckle H; Schollmeyer P; Hörl WH
    Kidney Int Suppl; 1989 Nov; 27():S264-8. PubMed ID: 2636668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of long-term treatment with L-carnitine on dyslipemia in hemodialysis patients].
    Dionisio P; Bergia R; Caramello E; Graziola M; Valenti M; Bajardi P; Barbera L; Voglino F
    Minerva Med; 1985 Feb; 76(6):229-34. PubMed ID: 3974937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of L-carnitine supplementation on muscular symptoms in hemodialyzed patients.
    Sakurauchi Y; Matsumoto Y; Shinzato T; Takai I; Nakamura Y; Sato M; Nakai S; Miwa M; Morita H; Miwa T; Amano I; Maeda K
    Am J Kidney Dis; 1998 Aug; 32(2):258-64. PubMed ID: 9708610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of L-carnitine on lipid metabolism in patients on chronic haemodialysis.
    Yderstraede KB; Pedersen FB; Dragsholt C; Trostmann A; Laier E; Larsen HF
    Nephrol Dial Transplant; 1987; 1(4):238-41. PubMed ID: 3110681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma and muscle carnitine in healthy and hemodialyzed children.
    Glöggler A; Bulla M; Puchstein C; Gulotta F; Fürst P
    Child Nephrol Urol; 1988-1989; 9(5):277-82. PubMed ID: 3271594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral carnitine therapy in children with cystinosis and renal Fanconi syndrome.
    Gahl WA; Bernardini I; Dalakas M; Rizzo WB; Harper GS; Hoeg JM; Hurko O; Bernar J
    J Clin Invest; 1988 Feb; 81(2):549-60. PubMed ID: 3276734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of L-carnitine on respiratory function tests in children undergoing chronic hemodialysis.
    Kavukçu S; Türkmen M; Salman S; Onvural B; Oktay G; Karaman O; Cevik NT
    Turk J Pediatr; 1998; 40(1):79-84. PubMed ID: 9673532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the effect of d,l-carnitine on lipid metabolism of patients after prolonged dialysis].
    Król E; Rutkowski B; Manitius J; Manitius A; Sałek J; Wróblewska M; Lysiak-Szydłowska W
    Pol Tyg Lek; 1991 Aug 5-19; 46(32-34):614-6. PubMed ID: 1669126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of L-carnitine supplementation on secondary hyperparathyroidism and bone metabolism in hemodialyzed patients.
    Cibulka R; Racek J; Pikner R; Rajdl D; Trefil L; Vesela E; Studenovska M; Siroka R
    Calcif Tissue Int; 2007 Aug; 81(2):99-106. PubMed ID: 17622482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carnitine and hemodialysis.
    Bellinghieri G; Santoro D; Calvani M; Mallamace A; Savica V
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S116-22. PubMed ID: 12612967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carnitine deficiency in children and adolescents with type 1 diabetes.
    Mamoulakis D; Galanakis E; Dionyssopoulou E; Evangeliou A; Sbyrakis S
    J Diabetes Complications; 2004; 18(5):271-4. PubMed ID: 15337500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total carnitine and acylated carnitine ratio: relationship of free carnitine with lipid parameters in pediatric dialysis patients.
    Marín VB; Azocar M; Molina M; Guerrero JL; Ratner R; Cano F
    Adv Perit Dial; 2006; 22():130-5. PubMed ID: 16983956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-carnitine in haemodialysed patients. Changes in lipid pattern.
    Casciani CU; Caruso U; Cravotto E; D'Iddio S; Corsi M; Pola P; Savi L; Grilli M
    Arzneimittelforschung; 1982; 32(3):293-7. PubMed ID: 7200788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of long-term intravenous high dose B-complex vitamins with or without folic acid on serum homocysteine in hemodialysis patients.
    Sombolos K; Fragia T; Natse T; Bartholomatos G; Karagianni A; Katsaris G; Christidou F; Bamichas G; Stangou M; Papagalanis N
    J Nephrol; 2002; 15(6):671-5. PubMed ID: 12495282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of L-carnitine infusions on inflammatory and nutritional markers in haemodialysis patients.
    Duranay M; Akay H; Yilmaz FM; Senes M; Tekeli N; Yücel D
    Nephrol Dial Transplant; 2006 Nov; 21(11):3211-4. PubMed ID: 16861734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscle carnitine repletion by long-term carnitine supplementation in nephropathic cystinosis.
    Gahl WA; Bernardini IM; Dalakas MC; Markello TC; Krasnewich DM; Charnas LR
    Pediatr Res; 1993 Aug; 34(2):115-9. PubMed ID: 8233709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.